# Protective Role of Alpha-Lipoic Acid in Chemotherapy-Induced Mucositis

> **NCT07736495** · PHASE2,PHASE3 · RECRUITING · sponsor: **Ain Shams University** · enrollment: 50 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** alpha lipoic acid 600 mg twice daily
- **OTHER:** Placebo Tablet

## Key facts

- **NCT ID:** NCT07736495
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-27
- **Primary completion:** 2026-12-27
- **Final completion:** 2026-12-29
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07736495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07736495, "Protective Role of Alpha-Lipoic Acid in Chemotherapy-Induced Mucositis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07736495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*